Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation

As Moderna’s COVID vaccine patent lawsuits wind their way through courts around the globe, Pfizer and BioNTech contend their rival is trying to monopolize the entire mRNA field.